Joint impact of donor and recipient parameters on the outcome of liver transplantation in Germany

Transplantation

Volumn 92, Issue 12, 2011, Pages 1378-1384

  Frühauf, Nils R ^a   Fischer Fröhlich, Carl Ludwig ^b   Kutschmann, Marcus ^c   Schmidtmann, Irene ^d   Kirste, Günter ^e  

^a Deutsche Stiftung Organtransplantation   (Germany)

^b Deutsche Stiftung Organtransplantation   (Germany)

^c BQS Institute for Quality and Patient Safety   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e Deutsche Stiftung Organtransplantation ^*  (Germany)

Author keywords

Donor characteristics; Extended donor criteria; Liver transplantation; Nationwide study; Patient and graft survival

Indexed keywords

BILIRUBIN; CREATININE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DONOR SELECTION; FEMALE; GERMANY; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SURGICAL RISK; SURVIVAL RATE; AGE; BODY MASS; DONOR; FACTUAL DATABASE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; DATABASES, FACTUAL; FEMALE; GERMANY; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84858431112     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318236cd2f     Document Type: Article

References (24)

1. Deutsche Stiftung Organtransplatnation. Organ donation and transplantation in Germany 2009, annual report. Frankfurt, Germany, Deutsche Stiftung Organtransplatnation 2010. Available at: http://www.dso.de/pdf/DSO- JB2009-e.pdf. Accessed February 18, 2011.
2. Durrand F, Renz JF, Alkofer B, et al. Report of the Paris consensus meeting on expanded criteria in liver transplantation. Liver Transpl 2008; 14: 1694.
3. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651.
4. Cameron AM, Ghobrial RM, Yersiz H, et al. Optimal utilization of donor grafts with extended criteria: A single-center experience in over 1000 liver transplants. Ann Surg 2006; 243: 748.
5. Axelrod DA, Schnitzler M, Salvalaggio PR, et al. The economic impact of the utilization of liver allografts with high donor risk index. Am J Transplant 2007; 7: 990.
6. German Medical Association (Bundesaerztekammer). Richtlinien zur Organtransplantation nach §16 TPG, Ä nderung. Dtsch Arztebl 2004; 101: A246.
7. German Medical Association (Bundesärztekammer). Bekanntmachungen: Richtlinien zur Organtransplantation gemäß § 16 TPG. Dtsch Arztebl 2006; 103: A-3282/B-2858/C-2738.
8. Schaubel DE, Sima CS, Goodrich NP, et al. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008; 8: 419.
9. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783.
10. Fischer-Fröhlich CL, Lauchart W. Expanded criteria liver donors (ECD): Effect of cumulative risks. Ann Transplant 2006; 11: 38.
11. Mauer D, Nehammer K, Boesebeck D, Wesslau C. Die organprotektive Intensivtherapie bei postmortalen Organspenden. Intensivmed 2003; 40: 574.
12. Deutsche Stiftung Organtransplantation: Organspende-eine gemeinsame Aufgabe [ed. 2]. Neu Isenburg, Germany, Deutsche Stiftung Organtransplantation 2003. Available at: http://www.dso.de/fachinformationen/informationsordner/pdf/ informationsordner.pdf. Accessed February 18, 2011.
13. Zaroff JG, Rosengard BR, Armstrong WF, et al. Consensus conference report: Maximizing use of organs recovered from the cadaver donor: Cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation 2002; 106: 836.
14. Council of Europe. Guide to safety and quality assurance for the transplantation of organs, tissues and cells [ed. 4]. Strasbourg, France, Council of Europe 2011.
15. Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997; 64: 248.
16. Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001; 21: 105.
17. Verran D, Kusyk T, Painter D, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003; 9: 500.
18. Zamboni F, Franchello A, David E, et al. Effect of macrovesicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transplant 2001; 15: 53.
19. Briceño J, Ciria R, de la Mata M, et al. Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era. Transplantation 2010; 90: 530.
20. Segev DL, Maley WR, Simpkins CE, et al. Minimizing risk associated with elderly donors by matching to preferred recipients. Hepatology 2007; 46: 1907.
21. Volk ML, Reichert HA, Lok AS, et al. Variation in organ quality between liver transplant centers. Am J Transplant 2011; 11: 958.
22. Porte RJ, Lisman T, Tripod A, et al.; Coagulation in Liver Disease Study Group. The International Normalized Ratio (INR) in the MELD score: Problems and solutions. Am J Transplant 2010;10: 1349.
23. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864.
24. Merion RM, Goodrich NP, Feng S. How can we define expanded criteria for liver donors? J Hepatol 2006; 45: 484.